Clinical Value of Circulating Microribonucleic Acids miR-1 and miR-21 in Evaluating the Diagnosis of Acute Heart Failure in Asymptomatic Type 2 Diabetic Patients.

Biomolecules 2019 05 17;9(5). Epub 2019 May 17.

Department of Biochemistry, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul 34098, Turkey.

To investigate whether the circulating miR-1 (microRNA-1) and miR-21 expression might be used in the diagnosis of heart failure (HF) and silent coronary artery disease (SCAD) in asymptomatic type 2 diabetes mellitus (T2DM) patients and to explore the relationship of these miRs with N-terminal pro-brain natriuretic peptide (NT-proBNP) and galectin-3. One hundred thirty-five consecutive patients with T2DM and 45 matched control subjects were enrolled in the study. This study consisted of the following four groups: control group (mean age: 60.23 ± 6.27 years, female/male (F/M): 23/22); diabetic group (DM) (mean age: 61.50 ± 5.08, F/M: 23/22); DM + SCAD group (mean age: 61.61 ± 6.02, F/M: 20/25); and DM + acute HF group (mean age: 62.07 ± 5.26 years, F/M: 20/25). miR-1 was downregulated in the DM, CAD + DM and HF + DM groups by 0.54, 0.54, and 0.12 fold as compared with controls, respectively. The miR-1 levels were significantly lower in HF + DM than DM with 0.22 fold changes ( < 0.001); and in patients with CAD + DM group with 0.22 fold changes ( < 0.001). Similarly, miR-21 was overexpressed in patients with DM, CAD + DM, and HF + DM with 1.30, 1.79 and 2.21 fold changes as compared with controls, respectively. An interesting finding is that the miR-21 expression was significantly higher in the HF + DM group as compared with the CAD + DM group; miR-1 was negatively correlated with NT-proBNP ( = -0.891, < 0.001) and galectin-3 ( = -0.886, < 0.001) in the HF + DM group; and miR-21 showed a strongly positive correlation with ( = 0.734, < 0.001) and galectin-3 ( = 0.764. < 0.001) in the HF + DM group. These results suggest that the circulating decreased miR-1 and increased miR-21 expression are associated with NT-proBNP and galectin-3 levels in acute HF + DM. Especially the miR-21 expression might be useful in predicting the onset of acute HF in asymptomatic T2DM patients. The miR-21 expression is more valuable than the miR-1 expression in predicting cardiovascular events of acute HF and the combined analysis of miR-21 expression, galectin-3, and NT-proBNP can increase the predictive value of miR-21 expression.

Download full-text PDF

Source
http://dx.doi.org/10.3390/biom9050193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571732PMC
May 2019
1 Read

Publication Analysis

Top Keywords

mir-21 expression
28
group age
16
fold changes
12
mir-21
10
group
9
t2dm patients
8
asymptomatic type
8
expression
8
f/m 23/22
8
nt-probnp galectin-3
8
022 fold
8
0001 galectin-3
8
0001 group
8
expression predicting
8
cad group
8
patients cad
8
heart failure
8
changes 0001
8
compared controls
8
f/m 20/25
8

Similar Publications